Lv3
370 积分 2023-07-21 加入
P3.12C.04 Seribantumab Results in Robust and Durable Responses in NRG1 Fusion-Positive Non-Small Cell Lung Cancer: A Multi-Center Case Series
8天前
已关闭
Analysis of MET kinase domain rearrangement in NSCLC
8天前
已完结
Routine molecular profiling of patients with NSCLC
8天前
已完结
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
8天前
已完结
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions
9天前
已完结
TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China
10天前
已完结
New Role of Tumor Mutation Burden as a Predictor to Chemo/Targeted Therapy in Advanced Non-Small Cell Lung Cancer
11天前
已完结
Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing
11天前
已完结
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies
22天前
已完结
Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
22天前
已完结
皖公网安备34019202002308
